Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Jian Zhou ,Zhejiang ,China ,Taiwan ,Zhongshan ,Anhui ,Shanghai ,United States ,Hong Kong ,Suzhou ,Jiangsu ,Beijing ,Peking ,Macau ,Lin Shen ,Guangdong ,Chinese ,Innovent Biologics ,Adimab Incyte ,Eli Lilly ,Jun Guo ,Jianming Xu ,Prnewswire Innovent Biologics Inc ,University Cancer Hospital Institute ,University Cancer Hospital ,Md Anderson Cancer Center ,Key Laboratory Of Carcinogenesis ,Translational Research Ministry Of Education ,Fudan University ,Virtual Congress ,European Society For Medical Oncology ,Department Of Oncology ,Incyte Corporation ,European Society ,Medical Oncology ,Oesophagogastric Cancer ,First Results ,Mini Oral ,Professor Lin Shen ,Key Laboratory ,Translational Research ,Peking University Cancer Hospital ,Gastric Cancer ,Fifth Medical Center ,Professor Jun Guo ,Professor Jian Zhou ,Zhongshan Hospital ,Main Board ,Stock Exchange ,Hong Kong Limited ,Biologics License Application ,Cancer Center ,Mainland China ,Business ,Health ,Pr Newswire ,